Susquehanna International Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.33M Buy
294,198
+242,030
+464% +$2.74M ﹤0.01% 1718
2025
Q1
$602K Buy
52,168
+22,990
+79% +$265K ﹤0.01% 4099
2024
Q4
$247K Buy
29,178
+11,357
+64% +$96.2K ﹤0.01% 4998
2024
Q3
$206K Buy
17,821
+4,335
+32% +$50.2K ﹤0.01% 4781
2024
Q2
$159K Sell
13,486
-6,400
-32% -$75.4K ﹤0.01% 4890
2024
Q1
$236K Sell
19,886
-7,085
-26% -$84K ﹤0.01% 4493
2023
Q4
$330K Buy
26,971
+16,177
+150% +$198K ﹤0.01% 4420
2023
Q3
$104K Sell
10,794
-49,177
-82% -$474K ﹤0.01% 4906
2023
Q2
$540K Buy
59,971
+25,906
+76% +$233K ﹤0.01% 3517
2023
Q1
$268K Sell
34,065
-73,180
-68% -$575K ﹤0.01% 4540
2022
Q4
$725K Buy
+107,245
New +$725K ﹤0.01% 2725
2022
Q3
Hold
0
6541
2022
Q2
Sell
-12,558
Closed -$185K 6265
2022
Q1
$185K Sell
12,558
-17,865
-59% -$263K ﹤0.01% 4874
2021
Q4
$402K Sell
30,423
-10,449
-26% -$138K ﹤0.01% 4104
2021
Q3
$713K Buy
40,872
+2,819
+7% +$49.2K ﹤0.01% 3215
2021
Q2
$912K Sell
38,053
-27,967
-42% -$670K ﹤0.01% 3097
2021
Q1
$1.7M Sell
66,020
-9,563
-13% -$246K ﹤0.01% 2308
2020
Q4
$1.44M Buy
+75,583
New +$1.44M ﹤0.01% 2110
2019
Q3
Sell
-23,514
Closed -$521K 4745
2019
Q2
$521K Sell
23,514
-24,546
-51% -$544K ﹤0.01% 2876
2019
Q1
$1.38M Buy
48,060
+239
+0.5% +$6.84K ﹤0.01% 1052
2018
Q4
$944K Buy
+47,821
New +$944K ﹤0.01% 1541
2016
Q3
Sell
-4,583
Closed -$43K 3464
2016
Q2
$43K Buy
+4,583
New +$43K ﹤0.01% 3018